Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.
In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).
Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.
What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
Come spend your summer working with passionate colleagues and inspirational leaders, all while gaining world-class experience in one of the fast-growing biotechs in the Bay Area.
We are looking for a summer intern for the Legal and Intellectual Property Law departments to co-host. This person will be given the opportunity to have a varied workload of Corporate Legal, Compliance and Intellectual Property projects.
Responsibilities:
- Assist with contract reviews
- Support in policy drafting
- Conduct legal research and perform analysis
- Participate in the development of compliance training and monitoring efforts
- Learn about legal advice related to pharmaceutical sales and promotion, including fraud and abuse, interactions with healthcare professionals and patients, market access, and reimbursement and government price reporting
- Assist with data privacy research and policy development
- Conduct special projects for the intellectual property team, such as analyzing claim scope of patents, scientific literature review, drafting responses to USPTO office actions, and trademark and copyright review
- Deliver a department presentation at the end of the program
- Participate as a member of 2025 intern team group project that includes a company-wide presentation
Preferred Skills, Qualifications and Technical Proficiencies:
- Interest in healthcare law
- Interest in in-house legal support
- A scientific background and/or a degree in life sciences
- Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
- Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Preferred Education and Experience:
- 1st or 2nd year law student
The pay range that the Company reasonably expects to pay for this headquarters-based position is $25/hr - $31/hr; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.
Applicants must be currently authorized to work in the United States on a full-time basis.
For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.
Please visit our website at: https://www.corcept.com/
Corcept is an Equal Opportunity Employer
Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.
What We Do
Leading the field in the discovery of drugs that modulate the effects of cortisol.
The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol.
